Patients In Poland Research Articles

Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III.

Congenital dyserythropoietic anaemia type II (CDA II) is well known for glycosylation abnormalities affecting erythrocyte membrane glycoconjugates that encompass hypoglycosylation of band 3 glycoprotein and accumulation of glycosphingolipids: lactotriaosylceramides, neolactotriaosylceramide and polyglycosylceramides. These abnormalities were not observed in erythrocytes from patients with CDA of either type I or III. Recently, however, we have described a CDA type I patient in Poland with identical, though less pronounced, glycoconjugate abnormalities to those observed in patients with CDA type II. The abnormalities included partial unglycosylation of O-linked glycosylation sites in glycophorin A. These abnormalities are now reported in three Bedouin patients from Israel with CDA type I. In addition, the erythrocyte membranes of these patients exhibited highly increased globotetraosylceramide content. Glycoconjugate abnormalities were also present in erythrocyte membranes from three patients from Northern Sweden with CDA type III but they almost exclusively affected glycosphingolipids. In erythrocytes of all patients examined including one with CDA type II, polyglycosylceramides were significantly hypoglycosylated although, on a molar basis, their contents in erythrocyte membranes were increased. Thus, glycoconjugate abnormalities of varying intensity occur in erythrocyte membranes from all patients with CDA that were investigated.

Serum IgE levels in HIV-infected patients in Poland.

AllergyVolume 55, Issue 9 p. 894-894 Serum IgE levels in HIV-infected patients in Poland† A. Muszyńska, A. Muszyńska Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this authorJ. Kruszewski, J. Kruszewski Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this authorW. Halota, W. Halota Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this authorJ. Ślusarczyk, J. Ślusarczyk Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this authorM. Kłos, M. Kłos Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this author A. Muszyńska, A. Muszyńska Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this authorJ. Kruszewski, J. Kruszewski Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this authorW. Halota, W. Halota Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this authorJ. Ślusarczyk, J. Ślusarczyk Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this authorM. Kłos, M. Kłos Department of Allergology and Infectious DiseasesMilitary School of MedicineSzaserów 12800-909 WarsawPolandSearch for more papers by this author First published: 05 April 2002 https://doi.org/10.1034/j.1398-9995.2000.00737.xCitations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume55, Issue9September 2000Pages 894-894 RelatedInformation

Familial defective apolipoprotein B-100 in hypercholesterolemic patients in Poland

Familial defective apolipoprotein B-100 in hypercholesterolemic patients in Poland

Mutation Screening of Charcot-Marie-Tooth Patients in Poland.

Mutation Screening of Charcot-Marie-Tooth Patients in Poland.

Incidence and relationship between behavioural and psychological symptoms in Alzheimer's disease.

To evaluate the frequency and type of psychological and behavioural symptoms in Alzheimer's disease (AD) patients in Poland, in various stages of the disease. One hundred and sixty-nine patients with a diagnosis of probable AD in Global Deterioration (GDS) stages 3, 4, 5, 6 and 7 of dementia were examined in a search for behavioural and psychological symptoms. Behavioural and psychotic symptoms were most often found in GDS stages 5 and 6 of AD, except for depressive disorder, which was observed most frequently in GDS stage 4 and whose frequently decreased towards the terminal stages of dementia. From an analysis of the relationship between behavioural symptoms in the Polish AD patients, the following syndromes may be discriminated: psychotic syndrome (delusions and hallucinations), delusions with aggressive behaviour and hallucinations and anxiety. With more severe dementia, the syndromes, which could be the result of delirium, became more common. Diagnosis of delirium should be considered in moderately severe and severe dementia whenever a sudden change in patients' behaviour occurs.

Hepatitis G virus coinfection in chronic hepatitis B and C patients in Poland.

This study evaluated the epidemiology and impact of hepatitis G virus (HGV) infection in patients with chronic hepatitis B and C. Serum samples were obtained from 128 consecutive untreated patients with chronic hepatitis B (72 cases) or C (56 cases). The presence of HGV RNA was determined by PCR amplification of the 5'untranslated region; the sensitivity of the assays was ten template copy equivalents. The prevalence of HGV RNA in hepatitis B and C was found to be 25% and 34%, respectively. HGV-positive and HGV-negative patients did not differ with respect to risk factors for infection, age, sex, or alanine aminotransferase activity. Similarly, there was no difference in the severity of liver disease, as assessed with HAI score. In conclusion, we found a very high prevalence of HGV infection in chronic hepatitis B and C patients in Poland. Nevertheless, no evidence was found that HGV coinfection has any impact on the severity of the underlying disease.

Intraspecific variation of Echinococcus granulosus and related species with emphasis on their infectivity to humans

Four species are presently recognised within the genus Echinococcus, namely Echinococcus granulosus, E. multilocularis, E. oligarthrus and E. vogeli, which are infective to humans. Evidence for strain diversity within the species E. granulosus, previously mainly based on morphological, biological and biochemical features, has been principally confirmed by recent genetic studies. Several molecular techniques are now available which allow the identification of E. granulosus strains. Epidemiological evidence and molecular studies indicate that the so-called sheep, cattle and cervid strains of E. granulosus are infective to humans, while the horse, camel and pig strains may be less or not infective, but this question warrants further studies. A recent study indicates that E. granulosus infecting patients in Poland shares close molecular affinity with a genotype of pig origin (G7) but exhibits some clear differences. Therefore, it may represent a previously undescribed genotype of E. granulosus, designated as G9. Phylogenetic analysis of molecular data has demonstrated the need to reappraise the taxonomic status of currently recognised strains. Clear evidence for strain variation in the other species of Echinococcus does not exist at present.

Truth‐telling, Information, and Communication with Cancer Patients in Poland

Truth‐telling, Information, and Communication with Cancer Patients in Poland

270-PA11 Drug resistance in tuberculosis patients in Poland — the magnitude of the problem

270-PA11 Drug resistance in tuberculosis patients in Poland — the magnitude of the problem

Drug resistance in newly discovered untreated tuberculosis patients in Poland, 1974–1977

Between March 1974 and November 1977 altogether 2568 strains from 509 newly discovered, previously untreated tuberculosis patients from many areas of Poland were tested for susceptibility to 4 antituberculosis drugs: isoniazid (INH),streptomycin (SM), ethambutol (EMB) and rifampicin (RMP). Twenty seven patients (5.3%) were infected with tubercle bacilli resistant to 1 (4.1%) or 2 drugs (1.2%). Sixteen patients (3.1%) were infected with strains resistant to INH alone; 5 (1.0%) to SM alone and 6 (1.2%) to both INH and SM. Twenty two cases (4.3%) were resistant to INH and 11 cases (2.1%) to SM. No bacilli resistant to EMB or RMP, alone or in combination, were found. No relationship was found between sex or age and primary resistance rates.